<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-100024" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Total Occlusion of the Coronary Artery</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafeez</surname>
            <given-names>Yamama</given-names>
          </name>
          <aff>Deborah Heart and Lung Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Varghese</surname>
            <given-names>Vincent</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yamama Hafeez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vincent Varghese declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-100024.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic total occlusion (CTO) lesions are diagnosed in patients who are undergoing coronary angiography as part of the evaluation of ischemic heart disease, cardiomyopathy, or valvular heart disease. CTO revascularization has not shown benefit in rates of all-cause mortality, myocardial infarction, stroke, and repeat revascularization and is commonly performed to improve a patient's quality of life by reducing their angina symptoms. This activity reviews the evaluation and treatment of chronic total occlusion of the coronary artery and highlights the role of the interprofessional team in evaluating and treating this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the histopathology of a chronic total occlusion (CTO) lesion.</p></list-item><list-item><p>Review the risk factors for developing chronic total occlusion (CTO) lesions.</p></list-item><list-item><p>Outline the typical presentation of a patient with chronic total occlusion (CTO) lesions.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst the interprofessional team( primary care physician, cardiologist, and interventionist) to enhance the delivery of care for patients with chronic total occlusion (CTO).</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=100024&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=100024">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-100024.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A coronary chronic total occlusion (CTO) is defined as 100% occlusion of a coronary artery for a duration of greater than or equal to 3 months based on angiographic evidence. The TIMI (thrombolysis in myocardial infarction) flow grading system is a scoring classification from 0-3 referring to the levels of coronary blood flow assessed during coronary angiography. The TIMI flow grading system is as below<xref ref-type="bibr" rid="article-100024.r1">[1]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>TIMI 0 flow (no perfusion-complete occlusion) - the absence of any forward flow beyond a coronary occlusion.</p>
          </list-item>
          <list-item>
            <p>TIMI 1 flow (penetration without perfusion) - faint forward flow beyond the occlusion, associated with an incomplete filling of the distal coronary bed.</p>
          </list-item>
          <list-item>
            <p>TIMI 2 flow (partial reperfusion) - delayed forward flow with complete filling of the distal coronary bed.</p>
          </list-item>
          <list-item>
            <p>TIMI 3 flow (full perfusion) - normal flow, which fills the distal coronary bed.</p>
          </list-item>
        </list>
        <p>A "true" CTO is defined as 100% occlusion of a coronary artery with TIMI 0 flow; whereas a "functional" CTO is defined as severely stenotic, yet, less than a 100% occlusion of the coronary artery with TIMI 1 flow for a duration of greater than or equal to 3 months based on angiographic evidence.<xref ref-type="bibr" rid="article-100024.r2">[2]</xref> Moreover, it is difficult to identify the exact period over which a CTO lesion is present in the absence of serial angiograms. Therefore, it is mostly estimated based on available clinical information related to the timing of the event that caused the occlusion, for example, prior myocardial infarction or sudden change in anginal symptoms with electrocardiogram changes consistent with the location of the occlusion. However, in many patients, the age of the CTO cannot be determined with confidence.</p>
      </sec>
      <sec id="article-100024.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Risk factors for CTO lesion in patients are as below<xref ref-type="bibr" rid="article-100024.r3">[3]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Known coronary artery disease or history of myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Excessive tobacco use</p>
          </list-item>
          <list-item>
            <p>High LDL cholesterol, low HDL cholesterol</p>
          </list-item>
          <list-item>
            <p>Diabetes</p>
          </list-item>
          <list-item>
            <p>Sedentary lifestyle</p>
          </list-item>
          <list-item>
            <p>Hypertension</p>
          </list-item>
          <list-item>
            <p>Family history of premature disease</p>
          </list-item>
          <list-item>
            <p>End-stage kidney disease</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Postmenopausal women</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-100024.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CTO lesions are found in approximately one-quarter to one-third of patients undergoing diagnostic coronary angiography. The true prevalence, however, in the general population is unknown due to a subset of patients with CTO lesions being asymptomatic or minimally symptomatic and never undergoing diagnostic coronary angiography. Patients with a history of coronary artery bypass graft surgery are found to have CTOs of their native vessels more frequently (50% to 55%). In comparison, patients presenting with ST-elevation myocardial infarction (STEMI) are less likely to have a CTO (9%&#x000a0;to 11%).<xref ref-type="bibr" rid="article-100024.r4">[4]</xref><xref ref-type="bibr" rid="article-100024.r5">[5]</xref>&#x000a0;</p>
        <p>Data from the National Heart, Lung, and Blood Institute (1997&#x02013;1999) Dynamic Registry showed that CTO lesions are most common in the right coronary artery and least common in the left circumflex artery. Older patients are more likely to have at least one CTO lesion with 37% prevalence in patients under the age of &#x000a0;65 years, 40% in patients between the ages of 65&#x000a0;to 79 years, and 41% in those patients who are older than 85 years.<xref ref-type="bibr" rid="article-100024.r6">[6]</xref></p>
      </sec>
      <sec id="article-100024.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Pathogenesis of coronary artery disease, which can progress to CTO lesions, has multiple contributing factors, which include upregulation of the immunologic and inflammatory markers (cytokines, leukocytes, high sensitivity C-reactive protein),&#x000a0; endothelial dysfunction, and cholesterol accumulation. Most commonly, it starts with the collection of smooth muscle cells within the intima, and this progresses to macrophages accumulating in the intima leading to pathologic intimal thickening and progression of lesions.<xref ref-type="bibr" rid="article-100024.r7">[7]</xref><xref ref-type="bibr" rid="article-100024.r8">[8]</xref></p>
      </sec>
      <sec id="article-100024.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological attributes of a CTO lesion commonly consist of calcium, lipids (both intracellular and extracellular), smooth muscle cells, an extracellular matrix, and neovascularization. Occlusions typically have a dense concentration of collagen-rich fibrous tissue at the proximal and distal ends contributing to a columnar lesion of calcified, resistant fibrous tissue surrounding a softer core of organized thrombus and lipids. Lesion classification is as soft, hard, or a mixture of both. Soft plaques are more frequent in occlusions less than 12 months of age and consist of cholesterol-laden cells and foam cells. Hard plaques are more prevalent in occlusions that are older than 12 months of age and are characterized by dense fibrous tissue with fibrocalcific regions without neovascular channels.<xref ref-type="bibr" rid="article-100024.r9">[9]</xref></p>
      </sec>
      <sec id="article-100024.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>CTO lesions are diagnosed in patients who are undergoing coronary angiography as part of the evaluation of ischemic heart disease, cardiomyopathy, or valvular heart disease. Patients with ischemic heart disease generally present with typical chest pain symptoms (stable or unstable angina), atypical chest pain, NSTEMI, or STEMI. In contrast, patients with different types of cardiomyopathies or valvular heart disease may present with a variety of symptoms, including decompensated congestive heart failure. Therefore, during history taking in patients suspected of having ischemic heart disease, it is essential to have them describe and subjectively quantify their symptoms.</p>
        <p>The history should also include risk factors for cardiovascular disease (diabetes, tobacco abuse, hypertension, hyperlipidemia) and non-cardiac causes of the patient's symptoms, including pulmonary embolism, aortic dissection, pneumothorax, esophageal rupture or perforating peptic ulcer. Physical examination in these patients should include complete auscultation of the heart and lung sounds together with assessment for heart failure signs including jugular venous distention, Kussmaul sign, hepatojugular reflex, ascites, and peripheral edema.</p>
      </sec>
      <sec id="article-100024.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A significant component of an assessment for a patient who presents with signs and symptoms of ischemic heart disease is history and physical exam. These should include vital signs (respiratory rate, blood pressure, temperature, and heart rate), review of the patient's medication list, and an electrocardiogram. During their evaluation, the patient should have an assessment for any underlying or comorbid valvular heart disease or heart failure.</p>
        <p>A healthcare provider should consider thyroid function testing, pulmonary function testing, routine blood work, including cardiac enzymes, chest X-ray, and echocardiography as part of their initial evaluation. If the initial assessment and evaluation are performed on an urgent basis, intravenous access should be obtained and, if no contraindication exists, the patient should be administered aspirin (162 to 325 mg) and nitrates. If available, patients should be placed on a cardiac monitor and should be assessed with pulse oximetry for the need for supplemental oxygen.</p>
      </sec>
      <sec id="article-100024.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>CTO revascularization has not shown to benefit rates of all-cause mortality, myocardial infarction, stroke, or repeat revascularization; however, it has shown to significantly improve patients' quality of life and reduce symptoms of angina.<xref ref-type="bibr" rid="article-100024.r10">[10]</xref><xref ref-type="bibr" rid="article-100024.r11">[11]</xref><xref ref-type="bibr" rid="article-100024.r12">[12]</xref>&#x000a0;Nuclear medicine stress test or myocardial viability studies are also used in conjunction with symptoms to objectively demonstrate areas of ischemia or viability supplied by the CTO vessel. Based on current guidelines, patients with single-vessel CTO lesions should undergo coronary artery bypass surgery if they have left main artery disease, proximal LAD disease which supplies a viable anterior wall, or three-vessel disease in a patient with insulin-dependent diabetes, severe left ventricular dysfunction, or chronic kidney disease.<xref ref-type="bibr" rid="article-100024.r13">[13]</xref></p>
        <p>In patients who meet the indication for a CTO PCI, informed consent is necessary before the procedure after an extensive discussion about the risks and benefits of CTO PCI for the patient. Due to the challenging nature of the CTO lesions, a successful outcome for PCI in these lesions is when the procedure obtains TIMI-3 flow, and there is less than 50% of residual stenosis in the vessel.</p>
        <p>Multiple scoring systems are available to operators to predict technical success in CTO lesions. One of the most commonly used scoring systems is the J-CTO score, developed using the Chronic Total Occlusion Registry in Japan. A J-CTO score is used to predict the probability of crossing the CTO lesion within 30 minutes, and is inclusive of five independent factors; blunt stump appearance of the proximal cap of the occlusion, occlusion length greater than or equal to 20 mm, calcification detected within the CTO segment, the presence of a greater than 45-degree bend within the CTO segment, and prior failed PCI attempt of the CTO lesion. Each of these independent factors carries 1 point in the J-CTO score; zero is considered easy, a score of one is deemed to be intermediate, two rates as difficult, and greater than or equal to three is considered very difficult, with the probability of crossing within 30 minutes found to be 88%, 67%, 42%, and 10% respectively.<xref ref-type="bibr" rid="article-100024.r14">[14]</xref></p>
        <p>Another commonly used score to predict the technical success of CTO PCI is the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO) score. This predictor uses four independent factors to assess the CTO lesion, which includes CTO lesion proximal cap ambiguity, moderate/severe tortuosity of the CTO vessel, Circumflex artery CTO, and the absence of interventional collaterals. Each of these factors carries one point and correlates with technical success. &#x000a0;A PROGRESS-CTO score of 0 is associated with 91% technical success, a score of 1 correlates with 74%, a score of 2 is 57% percent, and a score of &#x02265;3 is less than 4.3%.<xref ref-type="bibr" rid="article-100024.r15">[15]</xref></p>
      </sec>
      <sec id="article-100024.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>STEMI</p>
          </list-item>
          <list-item>
            <p>NSTEMI</p>
          </list-item>
          <list-item>
            <p>Pulmonary embolism</p>
          </list-item>
          <list-item>
            <p>Aortic dissection</p>
          </list-item>
          <list-item>
            <p>Pneumothorax</p>
          </list-item>
          <list-item>
            <p>Esophageal rupture</p>
          </list-item>
          <list-item>
            <p>Perforating peptic ulcer disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-100024.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In addition to causing symptoms, CTOs have correlations with a worse overall prognosis, with higher rates of death and non-fatal adverse cardiovascular events in several populations. Patients with CTOs tend to be older and have more comorbidities and more significant impairment of left ventricular function. Furthermore, patients with non-revascularized CTOs have higher mortality and a higher risk of major adverse cardiovascular events in comparison to patients with multivessel coronary artery disease who are completely revascularized.<xref ref-type="bibr" rid="article-100024.r16">[16]</xref><xref ref-type="bibr" rid="article-100024.r17">[17]</xref></p>
      </sec>
      <sec id="article-100024.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Percutaneous coronary intervention (PCI) of a CTO lesion on average requires more fluoroscopy time, higher contrast volume, and carries a lower success rate compared to non-CTO PCI&#x02019;s. CTO PCIs also have a higher complication rate than non-CTO PCIs with major complications, including myocardial infarction, stroke, vessel perforation, and death. However, vascular access site complications during CTO PCI occur at a similar frequency as routine PCI; these include poorly controlled bleeding, hematoma, acute thrombosis, distal embolization, retroperitoneal hemorrhage, dissection of the access artery, arteriovenous fistula, and pseudoaneurysm. Other potentially serious complications include ventricular tachyarrhythmias, bradycardia, allergic reactions, atheroembolism, and contrast nephropathy.<xref ref-type="bibr" rid="article-100024.r18">[18]</xref><xref ref-type="bibr" rid="article-100024.r19">[19]</xref><xref ref-type="bibr" rid="article-100024.r20">[20]</xref><xref ref-type="bibr" rid="article-100024.r21">[21]</xref><xref ref-type="bibr" rid="article-100024.r22">[22]</xref><xref ref-type="bibr" rid="article-100024.r23">[23]</xref></p>
        <p>Data analysis of the National Cardiovascular Data Registry-Cath PCI Registry in the United States showed higher in-hospital major adverse cardiovascular event frequency (1.6 versus 0.8 percent; p&#x0003c;0.001) which included mortality (0.4 % versus 0.3%; p&#x0003c;0.001), stroke (0.1% versus 0.1 %; p = 0.045), tamponade (0.3% versus 0.1%; p&#x0003c;0.001), MI (2.7% versus 1.9 %; p&#x0003c;0.001), and urgent CABG surgery (0.8% versus 0.4%; p&#x0003c;0.001) in 22,365 patients who underwent CTO PCI compared with 572,145 patients who underwent non-CTO PCI. CTO PCIs also had lower procedural success rate (59% vs. 96%, p &#x0003c; 0.001) in this registry.<xref ref-type="bibr" rid="article-100024.r24">[24]</xref></p>
        <p>Another multicenter registry (OPEN-CTO) from 12 CTO-PCI centers of 1,000 consecutive patients undergoing CTO PCI evaluated success rates, complication rates, and health status benefits at one month. &#x000a0;CTO PCIs showed a success rate of 86%, with an in-hospital mortality of 0.9%, 1-month mortality of 1.3%. 4.8% of the patients had coronary perforations requiring treatment. Additionally, major adverse cardiovascular events were 7%, myocardial infarction 2.6%, acute kidney injury 0.7%, and stroke 0%.<xref ref-type="bibr" rid="article-100024.r12">[12]</xref></p>
      </sec>
      <sec id="article-100024.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education should include resources such as videos and pamphlets. Teaching should focus on risk factor reduction and lifestyle modification such as smoking cessation, blood pressure management based on guidelines, screening for new-onset diabetes, and exercise as tolerated.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-100024.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Educating patients at risk for&#x000a0;coronary artery disease&#x000a0;and making a closed-loop communication between them and their cardiologist for primary and secondary prevention can further&#x000a0;improve the management of patients at risk of these CTO lesions. Collaboration with shared decision making (between primary care physician, cardiologist, and interventionist) and communication&#x000a0;are&#x000a0;vital&#x000a0;elements for good outcomes in patients with coronary artery disease and CTO lesions.</p>
        <p>The interprofessional team care provided to the patient must use an integrated care pathway combined with an evidence-based approach to evaluating CTO lesions. The earlier angiographic and demographic predictors of failure to revascularize are identified in CTO lesions; the better is the prognosis and outcome.</p>
      </sec>
      <sec id="article-100024.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=100024&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=100024">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/100024/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=100024">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-100024.s16">
        <fig id="article-100024.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Coronary angiography with aortography showing occluded conus artery, Right Coronary Artery, Pulmonary Embolism Contributed by Wikimedia Commons, Goslar T., Podbregar M. (CC by 2.0) https://creativecommons.org/licenses/by/2.0/deed.en</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Acute_ECG_ST_segment_elevation_mimicking_myocardia.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-100024.s17">
        <title>References</title>
        <ref id="article-100024.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chesebro</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Knatterud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Dalen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dodge</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Hillis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ludbrook</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.</article-title>
            <source>Circulation</source>
            <year>1987</year>
            <month>Jul</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-54</page-range>
            <pub-id pub-id-type="pmid">3109764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ivanhoe</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Weintraub</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lembo</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Furman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gershony</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous transluminal coronary angioplasty of chronic total occlusions. Primary success, restenosis, and long-term clinical follow-up.</article-title>
            <source>Circulation</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-15</page-range>
            <pub-id pub-id-type="pmid">1728439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hajar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors for Coronary Artery Disease: Historical Perspectives.</article-title>
            <source>Heart Views</source>
            <year>2017</year>
            <season>Jul-Sep</season>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>109</fpage>
            <page-range>109-114</page-range>
            <pub-id pub-id-type="pmid">29184622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fefer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knudtson</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Galbraith</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Osherov</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Yalonetsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gannot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samuel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weisbrod</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bierstone</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sparkes</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <article-title>Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2012</year>
            <month>Mar</month>
            <day>13</day>
            <volume>59</volume>
            <issue>11</issue>
            <fpage>991</fpage>
            <page-range>991-7</page-range>
            <pub-id pub-id-type="pmid">22402070</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Claessen</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Dangas</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Weisz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Witzenbichler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guagliumi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000f6;ckel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brener</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial.</article-title>
            <source>Eur Heart J</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>768</fpage>
            <page-range>768-75</page-range>
            <pub-id pub-id-type="pmid">22240495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Selzer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kip</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Holubkov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Detre</surname>
                <given-names>KM</given-names>
              </name>
              <collab>NHLBI Dynamic Registry</collab>
            </person-group>
            <article-title>Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry.</article-title>
            <source>Am Heart J</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>146</volume>
            <issue>3</issue>
            <fpage>513</fpage>
            <page-range>513-9</page-range>
            <pub-id pub-id-type="pmid">12947372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitta</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Obata</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kodama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fujioka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawabata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kugiyama</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Jan</month>
            <day>27</day>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>323</fpage>
            <page-range>323-30</page-range>
            <pub-id pub-id-type="pmid">19161880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gawaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Dickfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Laugwitz</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Adelsberger</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Langenbrink</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neumeier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;mig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brand</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells.</article-title>
            <source>Circulation</source>
            <year>1998</year>
            <month>Sep</month>
            <day>22</day>
            <volume>98</volume>
            <issue>12</issue>
            <fpage>1164</fpage>
            <page-range>1164-71</page-range>
            <pub-id pub-id-type="pmid">9743506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moussa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Teirstein</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Dangas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Selmon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mitsudo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katoh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hoye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Grube</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Reifart</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Reisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abizaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.</article-title>
            <source>Circulation</source>
            <year>2005</year>
            <month>Oct</month>
            <day>11</day>
            <volume>112</volume>
            <issue>15</issue>
            <fpage>2364</fpage>
            <page-range>2364-72</page-range>
            <pub-id pub-id-type="pmid">16216980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grantham</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial.</article-title>
            <source>Circ Cardiovasc Qual Outcomes</source>
            <year>2010</year>
            <month>May</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>284</fpage>
            <page-range>284-90</page-range>
            <pub-id pub-id-type="pmid">20388873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joyal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Afilalo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rinfret</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis.</article-title>
            <source>Am Heart J</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>160</volume>
            <issue>1</issue>
            <fpage>179</fpage>
            <page-range>179-87</page-range>
            <pub-id pub-id-type="pmid">20598990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sapontis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salisbury</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Hirai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>McCabe</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Karmpaliotis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Pershad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wyman</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Spaedy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doshi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Federici</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Marso</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Nugent</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gosch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Grantham</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Early Procedural and Health Status Outcomes After Chronic Total Occlusion&#x000a0;Angioplasty: A Report From the OPEN-CTO Registry (Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion Hybrid Procedures).</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2017</year>
            <month>Aug</month>
            <day>14</day>
            <volume>10</volume>
            <issue>15</issue>
            <fpage>1523</fpage>
            <page-range>1523-1534</page-range>
            <pub-id pub-id-type="pmid">28797429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Reifart</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Moussa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hoye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Teirstein</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Selmon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mintz</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Katoh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Mitsudo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tamai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Grube</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Reisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dangas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mehran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abizaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Serruys</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.</article-title>
            <source>Circulation</source>
            <year>2005</year>
            <month>Oct</month>
            <day>18</day>
            <volume>112</volume>
            <issue>16</issue>
            <fpage>2530</fpage>
            <page-range>2530-7</page-range>
            <pub-id pub-id-type="pmid">16230504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morino</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Muramatsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ochiai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hiasa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Doi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hinohara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mitsudo</surname>
                <given-names>K</given-names>
              </name>
              <collab>J-CTO Registry Investigators</collab>
            </person-group>
            <article-title>Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-21</page-range>
            <pub-id pub-id-type="pmid">21349461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kandzari</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Jaffer</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Karmpaliotis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wyman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Alaswad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Grantham</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Moses</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Christakopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tarar</surname>
                <given-names>MNJ</given-names>
              </name>
              <name>
                <surname>Rangan</surname>
                <given-names>BV</given-names>
              </name>
              <name>
                <surname>Lembo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cipher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brilakis</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions: The PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Score.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2016</year>
            <month>Jan</month>
            <day>11</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">26762904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Racz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Walford</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era.</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>May</month>
            <day>23</day>
            <volume>113</volume>
            <issue>20</issue>
            <fpage>2406</fpage>
            <page-range>2406-12</page-range>
            <pub-id pub-id-type="pmid">16702469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Walford</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-25</page-range>
            <pub-id pub-id-type="pmid">19463393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Lozner</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pichard</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Vetrovec</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Noto</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications.</article-title>
            <source>Cathet Cardiovasc Diagn</source>
            <year>1989</year>
            <month>May</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-10</page-range>
            <pub-id pub-id-type="pmid">2720767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dorros</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cowley</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bentivoglio</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Block</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Bourassa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Detre</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gosselin</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gr&#x000fc;ntzig</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Kent</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Mock</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Mullin</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Myler</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Passamani</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Stertzer</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>DO</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.</article-title>
            <source>Circulation</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>723</fpage>
            <page-range>723-30</page-range>
            <pub-id pub-id-type="pmid">6218938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Complications associated with cardiac catheterization and angiography.</article-title>
            <source>Cathet Cardiovasc Diagn</source>
            <year>1982</year>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-11</page-range>
            <pub-id pub-id-type="pmid">7060118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noto</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Krone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Vetrovec</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&#x00026;I).</article-title>
            <source>Cathet Cardiovasc Diagn</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-83</page-range>
            <pub-id pub-id-type="pmid">1742788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laskey</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography &#x00026; Interventions.</article-title>
            <source>Cathet Cardiovasc Diagn</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>185</fpage>
            <page-range>185-90</page-range>
            <pub-id pub-id-type="pmid">8269487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyman</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Safian</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Portway</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Skillman</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Baim</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Current complications of diagnostic and therapeutic cardiac catheterization.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1988</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>1400</fpage>
            <page-range>1400-6</page-range>
            <pub-id pub-id-type="pmid">2973480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-100024.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brilakis</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Banerjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karmpaliotis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Shunk</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>KF</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Grantham</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry).</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>245</fpage>
            <page-range>245-253</page-range>
            <pub-id pub-id-type="pmid">25700746</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
